Neurology
Opinion
Are aging physicians a burden?
In our practice, the most common reason for those minor mistakes during our clinical evaluation is anxiety, said Dr. Nicolas Badre and Dr. Alan A...
News
FDA approves first oral treatment for spinal muscular atrophy
The oral treatment provided a “meaningful difference from the natural progression of the disease.”
News
FDA approves cannabidiol for tuberous sclerosis complex
The agency approved the drug for patients 1 year of age and older.
Conference Coverage
PANS may be more prevalent than thought
“If it’s acute onset, you’ve really got to think [PANS], and you should do that workup or refer to someone who does,” said Dr. Kiki D. Chang.
Article
Migraine headache pearls
Combining treatment with metoclopramide can be helpful.
Latest News
Internists’ use of ultrasound can reduce radiology referrals
The use of point-of-care ultrasound in internal medicine has been more controversial than in emergency medicine.
News
FDA expands Dysport use for cerebral palsy–related spasticity
This allows for more consistent therapy for children with cerebral palsy who have upper- and lower-limb spasticity.
Latest News
Daily Recap: Hospitalized COVID patients need MRIs; Americans vote for face masks
Orthopedists were the top earners, according to a new Medscape report on physician debt and net worth.
News
Three stages to COVID-19 brain damage, new review suggests
Patients with COVID-19 symptoms may have neurological symptoms that may become apparent only after hospital discharge.
News
FDA approves new treatment for Dravet syndrome
Children treated with fenfluramine experienced significantly greater reductions in the frequency of convulsive seizures than did their peers who...
Latest News
Daily Recap: Healthy lifestyle may stave off dementia; Tentative evidence on marijuana for migraine
“A short-term decline of this magnitude … is biologically implausible for MI and stroke.”